In this phase 3, randomized, open-label trial, insulin-naive adults (18 years of age) with type 2 diabetes (T2D) uncontrolled on metformin (with or without a sulphonylurea) were randomized 1:1:1:1 to weekly tirzepatide 5 mg, 10 mg or 15 mg or daily insulin glargine at 66 hospitals in China, South Korea, Australia and India
While most symptoms are mild and resolve within a few days, its important to recognize when they may require attention
Why it happens: GLP-1 slows stomach emptying, which increases fullness but can also trigger nausea
Zepbound (tirzepatide) is FDA-approved along with regular exercise and a reduced-calorie diet for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or higher (obesity) or 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea Mounjaro is approved by the FDA along with a reduced-calorie diet and regular exercise to improve blood sugar control in type 2 diabetics
In Study 8, 5.4% of patients treated with WEGOVY 7.2 mg and 1% patients treated with placebo permanently discontinued treatment as a result of adverse reactions
[116] [117] [118] Studies conducted on lettuce grown in saline soil conditions have shown that the application of melatonin significantly mitigates the harmful effects of salinity